Fertilize your imagination with research, Kunal Basu tells aspiring writers

[email protected] (CD Network)
February 24, 2016

Mangaluru, Feb 24: “Good stories are a product of daydreaming and to be a good writer one needs to continuously feed the daydreaming mind,” said internationally acclaimed author Dr Kunal Basu. He was addressing the delegates of National Seminar on Dislocation, Identities, Multiculturism and the Diaspora' organized by the Post Graduate Department of English, St Aloysius College in association with Pan Macmillan India publishing house.

farmers 1

Speaking on the creative process involved in writing, the author of five critically acclaimed novels including the recently released bestseller Kalkatta' said writing has no formula or standardized tool kit.

“Writing is a discipline developed on one's own. So I cannot tell you how to write, only how I write,” he said, “For me writing comprises three things – Impulse, Method and Appraisal. In order to generate fodder for my imagination, I expose myself to unfamiliar experiences in a planned manner. The excitement and curiosity create stories in mind, which I then put on paper.”

In exposing oneself of unfamiliar experiences, it important that one is not judgmental, he added. “I try to be more accepting of the world around me and the research in turn fertilizes my imagination.”

Besides being an author, Dr. Kunal Basu is a management educator presently serving as University Reader in Marketing at Saïd Business School, University of Oxford and a fellow of Green-Templeton College.

Earlier in his welcome address, Dr. Lourdusamy Arputhem, the chairman of the Post Graduate Department of English, said, “As teachers, we should know the undercurrents and nuances of the author, which may not be known to the lay reader.”

Dr Kunal Basu also released Scribblings', an anthology of poems written by the department students.

Fr Swebert D'Silva, Principal of the college presided over the inauguration ceremony of the seminar. Dr AM Narahari, Registrar of the college and a seminar resource person Dr Padma Baliga, Associate Professor of English, St Joseph's Autonomous College, Bangalore officiated on stage during the inauguration.

Another resource person Dr Rajalakshmi NK, Associate Professor of English, University College, Mangaluru and Vasant Kamat, Head of Product at Pan Macmillan India were present on the occasion. Dr Melisa Goveas proposed vote of thanks.

farmers 7

farmers 2

farmers 4

farmers 5

farmers 6

farmers 8

farmers 9

aloysiusBook 1

aloysiusBook 2

aloysiusBook 3

aloysiusBook 4

aloysiusBook 5

Comments

Honest
 - 
Thursday, 25 Feb 2016

Dear Writers,
Please read the QURAN atleast once in your life time. There are many helpful thoughts to you and the society which U and the society can benefits.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 11,2020

Bengaluru, Mar 11: The Insurance Regulatory Authority of India has asked insurers to settle all claims related to coronavirus expeditiously under existing health policies that provide for treatment of hospitalisation expenses.

It has also asked insurers to design products covering the cost of treatment of coronavirus that has fast spread across the world and also resulted in increasing number of infections in India. There has been over 3,000 deaths globally and 58 cases tested positive in India.

In order to provide need-based health insurance coverage, insurers are intro ducing products for various specific diseases, including vector borne diseases. "For the purpose of meeting health insurance requirements of various sections, insurers are advised to design products covering the costs of treatment for coronavirus," the IRDAI said in a circular.

The regulator said that under existing health insurance policies where hospitalisation is covered, not only the cases related to coronvirus disease (COVID-19) shall be expeditiously handled, but all the costs of admissible medic al expenses during the course of treatment, including the treatment during quarantine period, should be settled in accordance to the applicable terms and conditions of policy contract and the extant regulatory framework.

This would bring much needed relief to policy holders some of whom were facing difficulty in getting coverage for treatment takers to coronavirus. In the absence of clear information, a few hospitals were reportedly denying for forward such claims of policy holders to the insurers.

IRDAI has now said that all the claims reported under COVID-19 shall be thoro ughly reviewed by review committee before repudiating the claims. This would prevent blanket rejection of such claims.

But to get full claim for treatment of coronavirus, industry experts said, a person should be hospitalised at least for 24 hours. Most insurers do not c over outpatient treatment.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 13,2020

New Delhi, Feb 13: Ashoka Buildcon on Thursday said it has emerged as the lower bidder for a highway project worth Rs 1,035.5 crore in Karnataka.

The project entails four laning of a section of NH-206 in the state.

Ashoka Buildcon had submitted its bid to National Highways Authority of India for the project to be built on hybrid annuity mode under Bharatmala Pariyojana, it said in a BSE filing.

"The company emerged as the lowest bidder at the financial bid opening meeting held on February 13," Ashoka Buildcon said.

The quoted bid project cost for the project is Rs 1,035.50 crore, it added.

The company's stock was trading at Rs 103.05, down 2.78 per cent, on the BSE.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 15,2020

Bengaluru, Jul 15: As on Wednesday, Bengaluru witnessed its first day of lockdown after rising number of Corona cases in the city. In a latest development, popular Kannada actor Dhruva Sarja and his wife Prerana Sarja have tested positive for COVID-19 sending shockwaves in the indutry.

Dhruva Sarja is the nephew of Arjun Sarja and younger brother of Chiranjeevi Sarja who passed away last month after suffering a massive heart attack.

The actor has requested people, who came in contact with them, to get tested immediately.

"My wife and I have both been tested positive for COVID-19 with mild symptoms and hence chosen to get ourselves hospitalised. I'm sure we'll be back all fine! All those who were in close proximity with us please get yourselves tested and remain safe," he tweeted.

In recent times, Mandya MP and popular actress Sumalatha Ambereesh too tested positive, now Dhruva Sarja is the second notable celebrity from Sandalwood to have tested positive for COVID-19.

A source close to the actor's family says that "During Chiranjeevi's funeral last month, some sections of people who had attended had also tested positive, as social distancing rules were not followed by those who attended the funeral. But now, the family has quarantined and there is no cause for worry. Dhruva has also requested all his primary contact to come forward voluntarily and get tested."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.